Grenoble-Isère leads innovation in the MedTech sector
Grenoble, November 24th, 2016 – UROMEMS, Aryballe Technologies, Surgivisio, Ecrins Therapeutics… major fundraising in recent weeks by Grenoble-Isère MedTech startups illustrates the vitality of the MedTech sector, supported by Invest in Grenoble-Isère, France – AEPI and the Medicalps cluster.
Medical technologies have the wind in their sails these days in Grenoble-Isère, where two innovative startups announced fundraising results in November. UROMEMS, a developer of implantable medical devices for urology, closed a 14 million euro financing round with €12 million from a pool of investors (Wellington Partners, Bpifrance, CEA Investissement and b-to-v Partners AG), plus another €2 million from the Worldwide Innovation Challenge. The funds will go towards finalizing the development of an “active artificial urinary sphincter” to improve the everyday comfort of people suffering from incontinence.
Another fundraiser, Aryballe Technologies, is a company that designs olfactory sensors. The Japanese Asahi Kasei Group invested €500,000, raising the startup’s share capital to €3.1 million. This followed a first round in June which raised €2.6 million from the Innovacom fund.
Thirteen Grenoble-Isère projects win Worldwide Innovation Challenge awards
Since early 2016, other Grenoble healthcare companies have also been attracting investor interest. They include Surgivisio (surgical navigation / €3 million), Ecrin Therapeutics (oncology / €560,000), BGene Genetics (biotech / €360,000), Fluoptics (medical imaging / €530,000) and Sublimed (pain treatment / €700,000).
The attractiveness of Grenoble startups is evidence of the Grenoble-Isère MedTech sector’s capacity for innovation. MedTech in Grenoble-Isère comprises 140 companies, including world leaders such as Roche Diagnostics, BD, BioMérieux and Fresenius, along with a host of startups, representing, in all, more than 10,000 jobs. The sector is backboned by a multidisciplinary scientific hub, internationally renowned for developing disruptive innovations and proposing new therapeutic approaches, from molecules to medical devices.
The sector is structured within the Medicalps hub, the lead in the French Tech in the Alps organization’s #HealthTech thematic network, and it also benefits from the longstanding support of Invest in Grenoble-Isère, France - AEPI. As a good sign of vitality, no fewer than 13 Grenoble healthcare projects — 10 of them from Medicalps members — recently won awards in the Worldwide Innovation Challenge organized by the French government to promote the development and growth of companies with the potential to deliver market-disrupting innovation.
Find out more in Medicalps announcement: http://www.medicalps.eu/2016/11/17/resultat-exceptionnel-france-cluster-medicalps-compte-10-laureats-concours-mondial-dinnovation/
About Invest in Grenoble-Isère, France-AEPI, promoting business development in Isère
Invest in Grenoble-Isère, France-AEPI’s mission is to promote Greater Grenoble and the Isère area, nationally and internationally, to attract new businesses. Invest in Grenoble-Isère, FRANCE-AEPI is a link between Isère and the world, with branches in the US, UK and Germany, and expanding operations in Asia (Taiwan and Korea), supported by Business France. Since 1997, AEPI has accompanied and assisted 465 French and non-French companies in setting up operations in the area, thereby contributing to the creation of 10,500 jobs. The Agency’s added value lies in creating favorable conditions for detecting, attracting, establishing and anchoring productive activities in Grenoble-Isère. The area’s strategic position at the crossroads of Industry, Research and Training and the presence of several competitive clusters make it an ideal place for those with a desire to create, undertake, innovate and invest. Join already 400 members and become a “Alpes Isère Ambassador”.
Find out more information: www.grenoble-isere.com and http://www.grenoble-isere.com/en/healthcare-technology
Twitter : @Grenoble_Isere